第十二届“类风湿关节炎国际论坛 (IFRA 2020)”会议日程

9月11日   星期五    下午13:30-18:20

时间

题目

讲者

主持

12:30-13:30

签到+专题视频

13:30-13:40

欢迎词

栗占国

叶  华

Session 1

13:40-14:10

Erosion repair in RA-is this possible?

谭麗珊

张奉春
黄慈波

14:10-14:35

RA细胞因子指纹图谱与JAKi

赵   岩

14:35-15:00

羟氯喹在RA并发心血管疾病的额外获益

张卓莉

鲍春德
张学武

15:00-15:25

RA患者围妊娠期的解决方案-Bedside to Bench Bedside

黄慈波

15:25-15:40

茶歇（专题视频）

Session 2

15:40-16:05

多管齐下，多重获益
---再谈新型DMARD的机制和临床新应用

穆   荣

曾小峰
孙凌云

16:05-16:30

以患者为中心，关注RA患者持续缓解

赵久良

16:30-16:55

类风湿关节炎的诊治思考

杨华夏

16:55-17:20

从机制角度看融合蛋白在RA慢病管理中的长期优势

苏   茵

Session 3

17:20-17:45

JAK-STAT通路在RA和免疫病理机制上的作用

穆   荣

朱   平
田新平

12th International Forum on Rheumatoid Arthritis (IFRA 2020)
Virtual Conference (Preliminary agenda)

Saturday, September 12th  08:00-18:00

Time

Topics

Speakers

Institutes

Chairs

08:00-08:10

Welcome and Opening Remarks

Zhanguo Li                Kazuhiko Yamamoto

Yuan Jia

Session 1

08:10-08:35

Integration of genetic information to immune functions
遗传因素对免疫功能的影响

Kazuhiko Yamamoto

RIKEN , Japan

Zhanguo Li
Yuan Jia

08:35-09:00

Understanding the effects of HLA on T cell repertoire
理解HLA对T细胞组库功能的影响

Soumya Raychaudhuri

Harvard Medical School, Boston, USA

09:00-09:25

Gut microbiota dysbiosis in the high-risk individual for RA triggers the mucosal immunity perturbation and promotes RA development
RA高风险个体的肠道微生物群失调触发黏膜免疫异常并促进RA发生发展

Yi Liu

Sichuan Univ. West China Hospital, China 

09:25-09:45

Panel Discussion
Panelists: Kazuhiko Yamamoto, Soumya Raychaudhuri, Yi Liu

Session 2

09:45-10:10

Identification of Novel Therapeutic Targets in Preclinical RA
临床前RA新治疗靶点的研究进展

Michael Holers

University of Colorado, Denver, USA

Yin Su
Jing He

10:10-10:35

Trans-layer omics analysis for RA
RA的多层次组学研究

Yukinori Okada

University of Osaka, Japan

10:35-11:00

MFAP5 regulates inflammation, synovial hyperplasia and joint damage in RA
MFAP5调控RA的炎症、滑膜增生和关节损伤

Huji Xu

Tsinghua Univ. Changgeng Hospital, China

11:00-11:20

Panel Discussion
Panelists: Michael Holers, Yukinori Okada, Huji Xu,Fanlei Hu

Session 3

11:20-11:45

Dietary modification in RA
RA患者的饮食调整

Debashish Danda

Christian Medical College, India

Chengde Yang
Jinxia Zhao

11:45-12:10

Recent advances in clinical and experimental studies of RA in China 
中国RA临床和实验研究的新进展

Zhanguo Li 

Peking Univ. People’s Hospital, China 

12:10-12:30

Panel Discussion
Panelists: Debashish Danda, Zhanguo Li, Jianping Guo,Yuan Jia

12:30-14:00

Lunch

Session 4

14:00-14:10

Opening Remarks

Lars Klareskog

Jianping Guo

14:10-14:35

Immunity to post-translationally modified antigens in RA; Origins and potential effector functions
RA特异性翻译后修饰抗原免疫；起源及潜在的效应功能

Lars Klareskog

Karolinska Institutet, Sweden

Zhuoli Zhang
Rong Mu

14:35-15:00

Pitfalls and optimization of RA and PsA clinical trial design
RA和PsA临床试验设计的经验教训及优化

Josef Smolen

Medical Univ. of Vienna, Austria

15:00-15:25

The testinal barrier dysfunction in the onset of rheumatoid arthritis
RA发病时睾丸屏障功能紊乱

George Schett

Friedrich Alexander Univ. of Erlangen-Nuremberg , Germany

15:25-15:45

Panel Discussion
Panelists: Lars Klareskog, Josef Smolen, George Schett, two Co-Chairs

Session 5

15:45-16:10

The evolution of the autoantibody response against post-translationally modified antigens in the disease course in RA
RA病程中针对翻译后修饰抗原的自身抗体反应的动态演变

Tom. W. J. Huizinga

Leiden Univ., The Netherlands

Mengtao Li
Guochun Wang

16:10-16:35

FOXP3+Treg functional stability and its clinical application
FOXP3+Treg功能稳态及其临床应用

Bin Li

Shanghai Jiao Tong Univ. , China 

16:35-16:55

Panel Discussion
Panelists: Tom. W. J. Huizinga, Xiaolin Sun, Hua Ye

Session 6

16:55-17:20

Integration of Omics data in study of response to treatment in RA
组学大数据在RA治疗反应研究中的应用

Leonid Padyukov

Karolinska Institutet, Sweden

Xuan Zhang
Ru Li